Management of Alveolar Proteinosis by Bronchopulmonary lavage under Extra Corporeal Membrane Oxygenation (ECMO)
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 1 (2016),
21 December 2015
,
Page 40-42
https://doi.org/10.22037/jcma.v1i1.10604
Abstract
The gold standard of treating Pulmonary Alveolar Proteinosis (PAP) is bronchopulmonary lavage (BPL). We describe a rare case of BPD for PAP, who underwent extracorporeal membrane oxygenation (ECMO) due to hypoventilation in the setting of one-lung ventilation. First, the clinical course of the patient is presented; furthermore, the biomolecular basis of PAP and new treatment approaches is discussed.
- Alveolar Proteinosis
- Bronchopulmonary lavage
- ECMO
How to Cite
References
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166(2):215-35.
Khan A, Agarwal R. Pulmonary alveolar proteinosis. Respir Care. 2011;56(7):1016-28.
Borie R, Danel C, Debray MP, Taille C, Dombret MC, Aubier M, et al. Pulmonary alveolar proteinosis. Eur Respir Rev. 2011;20(120):98-107.
Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010;135(2):223-35.
Leth S, Bendstrup E, Vestergaard H, Hilberg O. Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013. Respirology. 2013;18(1):82-91.
Trapnell BC, Luisetti M. The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2013;8:153.
Kim G, Lee SJ, Lee HP, Yoo CG, Han SK, Shim YS, et al. The clinical characteristics of pulmonary alveolar proteinosis: experience at Seoul National University Hospital, and review of the literature. J Korean Med Sci. 1999;14(2):159-64.
Doerschuk CM. Pulmonary alveolar proteinosis and macrophage transplantation. N Engl J Med. 2015;372(18):1762-4.
- Abstract Viewed: 245 times
- PDF Downloaded: 284 times